Quince Therapeutics is based in South San Francisco, CA. It has raised $115M in total funding.
Quince Therapeutics funding overview
Quince Therapeutics is based in South San Francisco, CA. Quince Therapeutics has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Quince Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Sofinnova Partners, Genextra SpA, Vanguard Global Advisers. 3 distinct backers are named across the disclosed rounds.
Quince Therapeutics at a glance
Total raised
$115M
Latest round date
May 2026
Headquarters
South San Francisco, CA
Notable investors
Sofinnova Partners, Genextra SpA, Vanguard Global Advisers
Frequently asked about Quince Therapeutics funding
How much has Quince Therapeutics raised?
Quince Therapeutics has raised $115M in total disclosed funding across the rounds on record.
Who has invested in Quince Therapeutics?
Sofinnova Partners, Genextra SpA, Vanguard Global Advisers are named among the investors backing Quince Therapeutics.
What was the latest Quince Therapeutics funding round?
No round stage has been disclosed for Quince Therapeutics.
Where is Quince Therapeutics based?
Quince Therapeutics is based in South San Francisco, CA.
When did Quince Therapeutics last raise?
The last disclosed Quince Therapeutics round closed in May 2026.
Every Quince Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.
